more interest in abuse-deterrent opioid formulations
You'll see more interest in abuse-deterrent opioid formulations.
This is stemming from the controversy surrounding the new long-acting hydrocodone med, Zohydro ER. It's NOT an abuse-deterrent form...despite concerns about its abuse potential.
Abuse-deterrent formulations aren't required by FDA yet...but are being promoted in an effort to reduce prescription opioid abuse.